John Higgins | Chief Executive Officer |
Matthew Korenberg | Executive Vice President, Finance and Chief Financial Officer |
Matthew Foehr | President and Chief Operating Officer |
Joseph Pantginis | H.C. Wainwright |
Lawrence Solow | CJS Securities |
Balaji Prasad | Barclays |
Matt Hewitt | Craig-Hallum Capital |
Scott Henry | ROTH Capital |
Dana Flanders | Guggenheim |
Good afternoon and thank you for standing by. Welcome to the Ligand Pharmaceuticals Quarter One Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] I would now like to hand the conference over to your speaker today, Mr.